Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment

References

• O'Neill J. Resistance TRoA. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance (wwwamr-revieworg), 2016.
   Google Scholar
• Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. Vaccines and antibiotic resistance. Curr Opin Microbiol 2012; 15:596-602; PMID:22981392; http://dx.doi.org/10.1016/j.mib.2012.08.002
   PubMed Web of Science ®Google Scholar
• Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816-20; PMID:10710308; http://dx.doi.org/10.1126/science.287.5459.1816
   PubMed Web of Science ®Google Scholar
• Felgner PL, Kayala MA, Vigil A, Burk C, Nakajima-Sasaki R, Pablo J, Molina DM, Hirst S, Chew JS, Wang D, et al. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A 2009; 106:13499-504; PMID:19666533; http://dx.doi.org/10.1073/pnas.0812080106
   PubMed Web of Science ®Google Scholar
• Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010; 33:530-41; PMID:21029963; http://dx.doi.org/10.1016/j.immuni.2010.09.017
   PubMed Web of Science ®Google Scholar
• Dennehy R, McClean S. Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections. Curr Protein Pept Sci 2012; 13:807-15; PMID:23305366; http://dx.doi.org/10.2174/138920312804871184
   PubMed Web of Science ®Google Scholar
• Tefon BE, Maass S, Ozcengiz E, Becher D, Hecker M, Ozcengiz G. A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins. Vaccine 2011; 29:3583-95; PMID:21397717; http://dx.doi.org/10.1016/j.vaccine.2011.02.086
   PubMed Web of Science ®Google Scholar
• Altindis E, Tefon BE, Yildirim V, Ozcengiz E, Becher D, Hecker M, Ozcengiz G. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 2009; 27:542-8; PMID:19028538; http://dx.doi.org/10.1016/j.vaccine.2008.11.020
   PubMed Web of Science ®Google Scholar
• Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T. Development of improved vaccines against whooping cough: current status. Hum Vaccin 2010; 6:543-53; PMID:20448470; http://dx.doi.org/10.4161/hv.6.7.11413
   PubMed Web of Science ®Google Scholar
• Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 2010; 6:e1001027; PMID:20686663; http://dx.doi.org/10.1371/journal.ppat.1001027
   PubMed Web of Science ®Google Scholar
• Malito E, Biancucci M, Faleri A, Ferlenghi I, Scarselli M, Maruggi G, Lo Surdo P, Veggi D, Liguori A, Santini L, et al. Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody. Proc Natl Acad Sci U S A 2014; 111:17128-33; PMID:25404323; http://dx.doi.org/10.1073/pnas.1419686111
   PubMed Web of Science ®Google Scholar
• McClean S, Healy ME, Collins C, Carberry S, O'Shaughnessy L, Dennehy R, Adams Á, Kennelly H, Corbett JM, Carty F, et al. Linocin and OmpW are involved in attachment of the cystic fibrosis-associated pathogen burkholderia cepacia complex to lung epithelial cells and protect mice against infection. Infect Immun 2016; 84:1424-37; PMID:26902727; http://dx.doi.org/10.1128/IAI.01248-15
   PubMed Web of Science ®Google Scholar
• Casey WT, Spink N, Cia F, Collins C, Romano M, Berisio R, Bancroft GJ, McClean S. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Vaccine 2016; 34:2616-21; PMID:27091689; http://dx.doi.org/10.1016/j.vaccine.2016.03.088
   PubMed Web of Science ®Google Scholar
• Holden MT, Seth-Smith HM, Crossman LC, Sebaihia M, Bentley SD, Cerdeno-Tarraga AM, Thomson NR, Bason N, Quail MA, Sharp S, et al. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009; 191:261-77; PMID:18931103; http://dx.doi.org/10.1128/JB.01230-08
   PubMed Web of Science ®Google Scholar
• Tomich M, Herfst CA, Golden JW, Mohr CD. Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun 2002; 70:1799-806; PMID:11895941; http://dx.doi.org/10.1128/IAI.70.4.1799-1806.2002
   PubMed Web of Science ®Google Scholar
• Mil-Homens D, Fialho AM. A BCAM0223 mutant of Burkholderia cenocepacia is deficient in hemagglutination, serum resistance, adhesion to epithelial cells and virulence. PLoS One 2012; 7:e41747; PMID:22848588; http://dx.doi.org/10.1371/journal.pone.0041747
   PubMed Web of Science ®Google Scholar
• Urban TA, Goldberg JB, Forstner JF, Sajjan US. Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun 2005; 73:5426-37; PMID:16113259; http://dx.doi.org/10.1128/IAI.73.9.5426-5437.2005
   PubMed Web of Science ®Google Scholar
• Nandi B, Nandy RK, Sarkar A, Ghose AC. Structural features, properties and regulation of the outer-membrane protein W (OmpW) of Vibrio cholerae. Microbiology 2005; 151:2975-86; PMID:16151208; http://dx.doi.org/10.1099/mic.0.27995-0
   PubMed Web of Science ®Google Scholar
• Rosenkrands I, Rasmussen PB, Carnio M, Jacobsen S, Theisen M, Andersen P. Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells. Infect Immun 1998; 66:2728-35; PMID:9596740
   PubMed Web of Science ®Google Scholar
• Shinoy M, Dennehy R, Coleman L, Carberry S, Schaffer K, Callaghan M, Doyle S, McClean S. Immunoproteomic analysis of proteins expressed by two related pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during human infection. PLoS One 2013; 8:e80796; PMID:24260482; http://dx.doi.org/10.1371/journal.pone.0080796
   PubMed Web of Science ®Google Scholar
• Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383-416; PMID:15831829; http://dx.doi.org/10.1128/CMR.18.2.383-416.2005
   PubMed Web of Science ®Google Scholar
• Nieves W, Heang J, Asakrah S, Honer zu Bentrup K, Roy CJ, Morici LA. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS One 2010; 5:e14361; PMID:21179405; http://dx.doi.org/10.1371/journal.pone.0014361
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A 2016; 113:1853-8; PMID:26755593; http://dx.doi.org/10.1073/pnas.1519690113
   PubMed Web of Science ®Google Scholar
• Madhavan G, Sangha K, Phelps C, Fryback D, Rappuoli R, Martinez RM, King L, editors. Ranking vaccines: a prioritization software tool: phase II: prototype of a decision-support system. Washington, DC: National Academies Press; 2013.
   Google Scholar